Wulandari Bangun Laksana Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Wulandari Bangun Laksana Tbk trades at Rp53 (market cap 1.35T, 281.8K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B). The key difference: Wulandari Bangun Laksana Tbk is far larger — about 8.2× Brigit Biofarmaka Teknologi Tbk.'s market cap. Which is the better fit depends on your goals.
| BSBK | OBAT | |
|---|---|---|
Market Cap | 1.35T | 164.65B |
Volume | 281.8K | — |
Lot | 2.82K | — |
Turnover | 14.94M | — |
Average Price | 53.01 | — |
Value | 14.94M | — |
Indicative Equilibrium Price | 54 | 238 |
Indicative Equilibrium Volume | 2.6K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Wulandari Bangun Laksana Tbk (the “Company”) was established under the name PT Dwipagrya Lestari in Jakarta based on Deed No. 21 dated September 7, 1994 by Linda Ibrahim, S.H., Notary in Jakarta. The Company commended its commercial operations on 2005.
Read more on BSBK →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →